What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease?
Olle RingdénM LabopinB SadeghiA MailholD BeelenY FløisandA GhavamzadehJ FinkeG EhningerL VolinG SociéN KrögerG StuhlerA GanserC SchmidS GiebelM MohtyA NaglerPublished in: Journal of internal medicine (2017)
HSCT patients who survive severe aGVHD have higher risk of developing extensive cGVHD, a higher NRM, a lower relapse probability, and lower LFS than other HSCT patients. This study is a platform for outcome analysis in patients treated with novel therapies for acute GVHD.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- liver failure
- peritoneal dialysis
- drug induced
- hematopoietic stem cell
- patient reported outcomes
- respiratory failure
- allogeneic hematopoietic stem cell transplantation
- intensive care unit
- acute lymphoblastic leukemia
- extracorporeal membrane oxygenation
- mechanical ventilation